TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS

METHOD OF COATING DRUG-ION EXCHANGE RESIN COMPLEXES

STABLE ORAL LIQUID COMPOSITIONS

METHOD OF TREATING AN ACUTE OR CHRONIC RESPIRATORY DISEASE IN A MAMMALIAN SUBJECT

MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

METHYLPHENIDATE MODIFIED RELEASE FORMULATIONS

MODIFIED RELEASE FORMULATIONS OF IBUDILAST

Dry Powdered Formulations

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

Sustained Release Pharmaceutical Composition Comprising Potassium Chloride

Compositions for Treatment of Attention Deficit Hyperactivity Disorder

HERBAL COMPOSITION FOR A TREATMENT OF HYPERTENSION, HYPERLIPIDEMIA, DIABETES, AND CARDIOVASCULAR RISK FACTORS

MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

ENTERIC AEROBIZATION THERAPY

PHARMACEUTICAL COMPOSITION AND METHOD FOR PRODUCING SAME

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF HUPERZINE AND METHODS OF USING THE SAME

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME

PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS

2,4-Dinitrophenol Formulations and Methods Using Same

MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS

NOVEL COMPOSITIONS

MUCO-ADHESIVE, CONTROLLED RELEASE FORMULATION OF LEVODOPA AND/OR ESTERS OF LEVODOPA AND USES THEREOF

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME

ENTERIC AEROBIZATION THERAPY

DROXIDOPA COMPOSITIONS AND METHODS

MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

Delayed Release Compositions of Linaclotide

Intestine-Targeted Drug Delivery Compositions and Preparation Methods Thereof

GAMMA-POLYGLUTAMIC ACID AND ZINC COMPOSITIONS

ORAL FORMULATION OF A PYRIDINONE DERIVATE AND USE THEREOF IN PROPHYLAXIS AND/OR TREATMENT OF INTESTINAL FIBROSIS

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Crystal Modifications of Odevixibat

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Dry Powdered Formulations

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

Enteric aerobization therapy

Method of using binary coating agents in powder coating to achieve enhanced properties of the coated powder and its blends having cohesive powders

Muco-adhesive, controlled release formulation of levodopa and/or esters of levodopa and uses thereof

WATER SOLUBLE COMPOSITIONS AND METHODS OF MAKING THE SAME

Modified release gamma- hydroxybutyrate formulations having improved pharmacokinetics

MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Liquid Resin Extended-Release Oral Naltrexone Formulation for Treating Autism-Related Disorders

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

INHALABLE HORMONE RECEPTOR AGONIST FORMULATIONS

CALCIUM LACTATE COMPOSITIONS AND METHODS OF USE

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

USE OF NITRATE AND VITAMIN C MICROCAPSULE FOR TREATING SICCA SYNDROME

PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS

Extended release compositions comprising pyridostigmine

ENCAPSULATION OF LIVE MICROORGANISMS

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Compositions for Treatment of Attention Deficit Hyperactivity Disorder

ALPELISIB FORMULATION

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES

ORAL PHARMACEUTICAL COMPOSITIONS OF DABIGATRAN ETEXILATE

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

ORAL AMPHETAMINE COMPOSITION

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

PHARMACEUTICAL FORMULATION OF ODEVIXIBAT

Low-Dose Stable Formulations of Linaclotide

ORAL SOLID CANNABINOID OIL COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISORDERS

COATED BETA HYDROXYBUTYRIC ACID CRYSTAL AND METHODS FOR PRODUCING THE SAME

PHARMACEUTICAL COMPOSITIONS

DOUBLE LAYERED DELAYED-RELEASE HARD CAPSULES

Delayed Release Compositions of Linaclotide

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

MULTIPARTICULATE DOSAGE FORMS COMPRISING DEUTETRABENAZINE

MICROENCAPSULATION PROCESS AND PRODUCT

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

Enteric aerobization therapy

Extended release compositions comprising pyridostigmine

Process to enhance the bioactivity of Ashwagandha extracts

MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

Enteric aerobization therapy

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Delayed Release Compositions of Linaclotide

Enriched Withania somnifera Based Dietary Composition and a Method Thereof

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

Controlled Release Formulations and Methods of Targeted Drug Delivery within the Small Intestine Wall

Extended release multiparticulates of ranolazine

DOSE DUMPING RESISTANT PHARMACEUTICAL COMPOSITIONS COMPRISING VERINURAD

PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1

Timed-elution masking particles and oral pharmaceutical composition containing the same

2,4-dinitrophenol formulations and methods using same

CONTROLLED RELEASE CORE-SHELL PARTICLES AND SUSPENSIONS INCLUDING THE SAME

MICROCAPSULE AND PRODUCTION METHOD THEREOF

Crystal modifications of odevixibat

NERVOUS SYSTEM CELL THERAPY

DOSE DUMPING RESISTANT PHARMACEUTICAL COMPOSITIONS COMPRISING VERINURAD

Water soluble compositions and methods of making the same

PROCESS FOR THE MANUFACTURE AND USE OF PANCREATIN MICROPELLET CORES

Calcium lactate compositions and methods of use

Sustained release solid dosage forms for modulating the colonic microbiome

Amantadine compositions, preparations thereof, and methods of use

Compositions for treatment of attention deficit hyperactivity disorder

Compositions for Treatment of Attention Deficit Hyperactivity Disorder

METHODS AND SYSTEMS FOR FORMING MULTI-LAYERED PARTICLES

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Extended release compositions comprising pyridostigmine

FORMULATIONS FOR ORAL DELIVERY OF ADSORBENTS IN THE GUT

METHODS AND COMPOSITIONS FOR THE TREATMENT OF SEIZURE-RELATED DISORDERS

Duloxetine sprinkles

Controlled Absorption Water-Soluble Pharmaceutically Active Organic Compound Formulation for Once-Daily Administration

Low-Dose Stable Formulations of Linaclotide

STABLE BENZIMIDAZOLE FORMULATION

Oral amphetamine composition

MODIFIED RELEASE GAMMA-HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS

Controlled release dosage form

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

Modified release pharmaceutical compositions of huperzine and methods of using the same

Orally disintegrating compositions

ENCAPSULATED CELLS PRODUCING CYTOCHROME P450 AND METHODS OF USE THEREOF

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

PROCESS FOR MANUFACTURING PHENYLEPHRINE RESINATE PARTICLES; PHENYLEPHRINE RESINATE PARTICLES; AND USE OF PHENYLEPHRINE RESINATE PARTICLES IN PHARMACEUTICAL FORMULATIONS

PHENYLEPHRINE RESINATE PARTICLES AND USE THEREOF IN PHARMACEUTICAL FORMULATIONS

METHODS FOR TREATING SUBJECTS WITH PRADER-WILLI SYNDROME OR SMITH-MAGENIS SYNDROME

METHOD FOR PRODUCING PARTICLE, AND PARTICLE PRODUCED BY THE METHOD AND MEDICAMENT

PEDIATRIC FORMULATION OF TYROSINE KINASE INHIBITORS

COMPOSITION OF CARBON DIOXIDE ABSORBENT OR ADSORBENT, WHEREBY THE SAID COMPOSITION CONTAINS A POLYMERIC COATING SELECTED FROM SILICONE RUBBER AND CELLULOSE DERIVATIVE

PARTICLES FOR ADMINISTRATION OF ACTIVE INGREDIENTS AND METHODS OF MAKING THE SAME

MODIFIED RELEASE GAMMA- HYDROXYBUTYRATE FORMULATIONS HAVING IMPROVED PHARMACOKINETICS

STABILIZED COATED BUTYRATE FOR COLON RELEASE

Oral pharmaceutical compositions of dabigatran etexilate

Pharmaceutical formulation of odevixibat

Methods and systems for forming layered solid particles

MULTIPARTICULATE INCLUDING PHARMACEUTICAL OR PROBIOTIC ACTIVE INGREDIENTS FOR DELIVERY VIA A SHELF STABLE LIQUID DOSAGE FORM

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Carrier composition for eye drops and pharmaceutical composition including the same

Pharmaceutical compositions comprising activated carbon

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

MOISTURE RESISTANT PROBIOTIC GRANULE AND METHODS OF PRODUCING THE SAME

Water soluble compositions and methods of making the same

Ophthalmic Delivery Device And Ophthalmic Active Agent Containing Compositions

Formulation

Controlled release core-shell particles and suspensions including the same

STABLE MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN

FEXOFENADINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

Composition comprising lactic acid bacteria improved in intestinal adherence by coating with silk fibroin

Process to enhance the bioactivity of Ashwagandha extracts

ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION

PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1

Duloxetine sprinkles

Extended release multiparticulates of ranolazine

Compositions for treatment of attention deficit hyperactivity disorder

Compositions for treatment of attention deficit hyperactivity disorder

Methods and systems for forming multi-layered particles

Extended release compositions comprising pyridostigmine

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

Sustained release solid dosage forms for modulating the colonic microbiome

Drug delivery systems comprising solid solutions of weakly basic drugs

Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix

Hypromellose acetate succinate powder excellent in dissolved state and production method thereof, and production methods for composition for solid dispersion, coating composition, drug-containing particle, and solid

Crystal modifications of odevixibat

Microcapsule and production method thereof

FREEZE-DRIED MULTIPARTICULATE SOLID DOSAGE FORM

Process for removing cobalt, lead, cadmium and chromium ions from bodily fluids using metallate ion exchange compositions

ENTERIC COATED PHARMACEUTICAL COMPOSITION AND USE THEREOF

Aqueous enteric coating composition

2,4-dinitrophenol formulations and methods using same

ABUSE-DETERRENT DRUG FORMULATIONS

Enterically coated cysteamine, cystamine and derivatives thereof

Ophthalmic delivery device and ophthalmic drug compositions

FEXOFENADINE MICROCAPSULES AND COMPOSITIONS CONTAINING THEM

Extended release liquid compositions of metformin

PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF

Arimoclomol formulation

Multiparticulate L-carnitine compositions and related methods

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

Colonic drug delivery formulation

Colonic drug delivery formulation

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Compositions for treatment of attention deficit hyperactivity disorder

Compositions for treatment of attention deficit hyperactivity disorder

Controlled release dosage form

Hypromellose acetate succinate powder excellent in dissolved state and production method thereof, and production methods for composition for solid dispersion, coating composition, drug-containing particle, and solid preparation

Microencapsulation process and product

Formulations of homotaurines and salts thereof

Compositions and methods for treating multiple sclerosis

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

ABUSE-DETERRENT DRUG FORMULATIONS

PHARMACEUTICAL FORMULATIONS OF NITRITE AND USES THEREOF

PHARMACEUTICAL COMPOSITIONS FOR TREATING ACNE

Duloxetine sprinkles

Amantadine compositions and preparations thereof

Timed, pulsatile release systems

Treating pain in patients with hepatic impairment

Microencapsulated chitosan, methods of making and methods for the use thereof

Oral cholestyramine formulation and use thereof

Oral cholestyramine formulation and use thereof

Low-Dose Stable Formulations of Linaclotide

PHARMACEUTICAL CYCLOSPORIN COMPOSITIONS

ORAL PHARMACEUTICAL COMPOSITION

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

STABLE MULTIPARTICULATE PHARMACEUTICAL COMPOSITION OF ROSUVASTATIN

Controlled absorption water-soluble pharmaceutically active organic compound formulation for once-daily administration

Drug delivery formulation for treating mental illness or central nervous system disorder

Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage Forms

Controlled release pharmaceutical compositions comprising a fumaric acid ester

System and method for industrial encapsulation of thermolabile substances

Oral amphetamine composition

DROXIDOPA COMPOSITIONS AND METHODS

Calcium lactate compositions and methods of use

Multiparticulates of spray-coated drug and polymer on a meltable core

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

PHARMACEUTICAL COMPOSITION COMPRISING AN ANTIEMETIC AGENT AND METHOD FOR THE PREPARATION THEREOF

Formulation of a micro drop pill and the preparation method thereof

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

Tamper-resistant pharmaceutical compositions of opioids and other drugs

Methods of using amantadine compositions

Controlled release dosage form

Colonic drug delivery formulation

Muco-adhesive, controlled release formulations of levodopa and/or esters of levodopa and uses thereof

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS FOR ACID-LABILE DRUGS

Multiparticulate including pharmaceutical or probiotic active ingredients for delivery via a shelf stable liquid dosage form

PHARMACEUTICAL COMPOSITIONS CONFIGURED TO DETER DOSAGE FORM SPLITTING

Controlled release doxycycline

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

TIME RELEASE OF FAT-SOLUBLE ACTIVES

Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics

TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS

Controlled release dosage form

PROCESS TO ENHANCE THE BIOACTIVITY OF ASHWAGANDHA EXTRACTS

COMPOSITION FOR THE TREATMENT OF DISEASE

Compositions for treatment of attention deficit hyperactivity disorder

Aqueous solution of cellulose ether acetate

Controlled release pharmaceutical compositions comprising a fumaric acid ester

Controlled release dosage form

Methods for treating subjects with Prader-Willi syndrome or Smith-Magenis syndrome

ABUSE RESISTANT DRUG FORMULATION

Solid simethicone particles and dosage form thereof

Polymer Shells

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate

Fexofenadine microcapsules and compositions containing them

Timed, pulsatile release systems

Prolonged release pharmaceutical composition comprising cysteamine or salt thereof

Method and apparatus for microneedle transdermal delivery

Enterically coated cysteamine, cystamine and derivatives thereof

Compositions comprising proton pump inhibitors

ENCAPSULATING AGENT WITH IMPROVED PROPERTIES ADAPTED FOR CELL ENCAPSULATION

MICROCAPSULES CONTAINING AN OXIDIZABLE ACTIVE, AND A PROCESS FOR PREPARING THE SAME

Formulations, methods, kit, and dosage forms for improved stability of an active pharmaceutical ingredient

MULTILAYERED PHARMACEUTICALLY ACTIVE COMPOUND-RELEASING MICROPARTICLES IN A LIQUID DOSAGE FORM

Controlled Release Dosage Form for Once Daily Administration of Dimethyl Fumarate

PULSATILE RELEASE PHARMACEUTICAL COMPOSITION COMPRISING NAFTAZONE OR ONE OF ITS SALTS

TAMPER-RESISTANT PHARMACEUTICAL COMPOSITIONS OF OPIOIDS AND OTHER DRUGS

Multiparticulate L-carnitine compositions and related methods

Formulations for oral delivery of adsorbents in the gut

PHARMACEUTICAL COMPOSITION COMPRISING A POTENT INHIBITOR OF URAT1

Multiphasic particles fabricated by wettability engendered templated self-assembly (WETS) methods

Extended release multiparticulates of ranolazine

Products containing charged polymer complex microcapsules and method of use

Treating pain in patients with hepatic impairment

MODIFIED RELEASE PHARMACEUTICAL COMPOSITIONS OF HUPERZINE AND METHODS OF USING THE SAME

Raloxifene sprinkle composition

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Oral amphetamine composition

Process for preparing formulations for gastrointestinal-targeted therapies

ABUSE RESISTANT DRUG FORMULATION

Process to enhance the bioactivity of ashwagandha extracts

ENCAPSULATED CELLS PRODUCING CYTOCHROME P450 AND METHODS OF USE THEREOF

STABLE BENZIMIDAZOLE FORMULATION

Compositions and methods for treating multiple sclerosis

DULOXETINE SPRINKLES

CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING A FUMARIC ACID ESTER

Microcapsules encapsulating a reflective agent

METHOD FOR TREATING INTESTINAL FIBROSIS

Multi-encapsulated formulations made with oxidized cellulose

ORAL LIQUID COMPOSITIONS OF GUANFACINE

EXTENDED RELEASE SUSPENSION COMPOSITIONS

Controlled release dosage form

Controlled release dosage form

Methods and compositions for the treatment of seizure-related disorders